Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockBearish
4
Neutral
4
Bullish
6
Bearish
29
Neutral
4
Bullish
13
Bearish
25
Neutral
0
Bullish
7
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
110.00 | 10,359 Cr | 15.90 | 2.34 | 1.33 | 9.62 | 11.96 | 1.68 | |
2616.05 | 8,396 Cr | 9.31 | 1.10 | 1.29 | 10.75 | 19.94 | 7.68 | |
6052.05 | 6,910 Cr | 8.21 | 0.68 | 0.82 | 8.05 | 4.77 | 2.75 | |
207.90 | 6,906 Cr | 68.33 | 2.34 | 0.00 | 3.62 | 4.60 | 1.03 | |
4570.00 | 5,054 Cr | 4192.66 | 0.30 | 0.33 | 0.17 | 1.38 | 0.40 | |
25.43 | 3,515 Cr | -8.53 | 3.40 | 0.00 | -40.63 | -16.68 | -12.64 | |
5813.70 | 2,988 Cr | 120.72 | 0.18 | 0.00 | 0.15 | 0.23 | 0.13 |
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q4 FY16
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY16
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY16
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY16
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Religare Enterprises Limited is a listed holding company and core investment company operating a diversified financial-services platform in India through majority stakes in Care Health Insurance (standalone health insurer), Religare Broking (retail broking and e‑governance), Religare Finvest (SME NBFC) and Religare Housing Development Finance Corporation (affordable housing finance).
The board has approved a strategic demerger to transfer the financial services businesses (lending, broking, ancillary services) into Religare Finvest Limited (RFL), with a 1:1 share swap and planned separate listing of RFL; the scheme targets regulatory approvals and a listing timeline of roughly 15–18 months, aiming to unlock value and simplify capital allocation.
Care Health Insurance is the group growth engine: GWP growth accelerated to Rs.7,906 crore for 9M FY26 (full premium basis), Care holds ~22% market share in SAHI, AUM of ~Rs.10,246 crore and solvency ratio of 1.70, while underwriting and operating leverage improved despite a one‑time labor code charge and transition to 1/n premium accounting.
Religare Broking posted resilient revenue and operating recovery with Q3 total income ~Rs.91 crore and improving PBT, assets under custody ~Rs.42,642 crore, while Religare Finvest reports a debt‑free balance sheet, CRAR at 228.2% and ~Rs.500+ crore cash, positioning the lending platform to re‑enter growth once leadership and operational plans are finalised.
Key near‑term risks include legacy litigation (LVB fixed deposit matter) and the accounting transition to 1/n reporting for insurance which depresses reported earned premium and ratios; simultaneously, material opportunities exist from capital infusions, demerger-driven clarity, underpenetrated lending and broking market expansion across digital and e‑governance channels.
Finance
NBFC-Holding Companies
6,906 Cr
Moderate Risk
68.3
22.8
—
2.3
314.15
199.80
Sales CAGR
Profit CAGR
ROE
ROCE
Religare Enterprises Ltd (RELIGARE) is currently trading at 207.90 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Religare Enterprises Limited is a listed holding company and core investment company operating a diversified financial-services platform in India through majority stakes in Care Health Insurance (standalone health insurer), Religare Broking (retail broking and e‑governance), Religare Finvest (SME NBFC) and Religare Housing Development Finance Corporation (affordable housing finance). The board has approved a strategic demerger to transfer the financial services businesses (lending, broking, ancillary services) into Religare Finvest Limited (RFL), with a 1:1 share swap and planned separate listing of RFL; the scheme targets regulatory approvals and a listing timeline of roughly 15–18 months, aiming to unlock value and simplify capital allocation. Care Health Insurance is the group growth engine: GWP growth accelerated to Rs.7,906 crore for 9M FY26 (full premium basis), Care holds ~22% market share in SAHI, AUM of ~Rs.10,246 crore and solvency ratio of 1.70, while underwriting and operating leverage improved despite a one‑time labor code charge and transition to 1/n premium accounting. Religare Broking posted resilient revenue and operating recovery with Q3 total income ~Rs.91 crore and improving PBT, assets under custody ~Rs.42,642 crore, while Religare Finvest reports a debt‑free balance sheet, CRAR at 228.2% and ~Rs.500+ crore cash, positioning the lending platform to re‑enter growth once leadership and operational plans are finalised. Key near‑term risks include legacy litigation (LVB fixed deposit matter) and the accounting transition to 1/n reporting for insurance which depresses reported earned premium and ratios; simultaneously, material opportunities exist from capital infusions, demerger-driven clarity, underpenetrated lending and broking market expansion across digital and e‑governance channels.
Over the past 52 weeks, Religare Enterprises Ltd has traded between a low of ₹199.80 and a high of ₹314.15. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Religare Enterprises Ltd has a market capitalization of approximately 6,905.81. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Religare Enterprises Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 68.33 and operates in the Finance sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 6,905.81 Cr, Religare Enterprises Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Religare Enterprises Ltd operates in the Finance sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Religare Enterprises Ltd is 68.33. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Regulatory Notice
Religare Enterprises reports its material subsidiary Care Health Insurance Ltd received an IRDAI show‑cause notice dated 02‑Mar‑2026 alleging breaches of multiple 2024 IRDAI circulars/regulations; CHIL is preparing a reply and taking remedial steps, and states no material impact on REL.
Regulatory Filing
Religare Enterprises reports its material subsidiary Care Health Insurance Ltd received an IRDAI show‑cause notice (dated Mar 2, 2026) from a Feb 2025 onsite inspection alleging violations of IRDAI master circulars; CHIL is preparing a reply and taking remedial steps and there is no material impact on REL.
